𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination therapy of bosentan and ambrisentan for portopulmonary hypertension

✍ Scribed by Muraoka, Hironori; Hatano, Masaru; Fujino, Takeo; Minatsuki, Shun; Imamura, Teruhiko; Inaba, Toshiro; Maki, Hisataka; Yao, Atsushi; Kinugawa, Koichiro; Komuro, Issei


Book ID
122170634
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
47 KB
Volume
93
Category
Article
ISSN
0024-3205

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Safety and efficacy of combined use of s
✍ Mark J. Austin; Neil I. McDougall; Julia A. Wendon; Elizabeth Sizer; Alex S. Kni πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 103 KB

Portopulmonary hypertension (PPHTN) represents a constrictive pulmonary vasculopathy in patients with portal hypertension. Liver transplantation (LT) may be curative and is usually restricted to patients with mild-to-moderate disease severity characterized by a mean pulmonary artery pressure (mPAP <